GH Axis · Placeholder catalog data
Ipamorelin
A pentapeptide growth hormone secretagogue receptor agonist developed as a research tool for selective GH release without significant cortisol or prolactin elevation in published preclinical models.
130 credits
Paid from your credit pool at checkout. Bulk quantities discount automatically.
Available variants
Pricing and fulfillment information is placeholder data.
| Amount | SKU | Credits | MSRP | Availability | Margin estimate |
|---|---|---|---|---|---|
| 5 mg | PTS-IPA-5 | 26 credits | $59 | Ready | 56% estimate |
| 10 mg | PTS-IPA-10 | 27 credits | $79 | Ready | 66% estimate |
Margin estimate treats 1 credit as $1 and compares estimated wholesale credit cost with placeholder MSRP. It excludes shipping, taxes, and other costs.
Buy more, save more
Quantity breaks apply per line item and are deducted automatically at checkout.
| Quantity per line | Discount | Example (5 mg unit) |
|---|---|---|
| 10+ units | 5% off | 10 × 26 credits → 247 credits |
| 25+ units | 10% off | 25 × 26 credits → 585 credits |
| 50+ units | 15% off | 50 × 26 credits → 1,105 credits |
| 100+ units | 20% off | 100 × 26 credits → 2,080 credits |
Specifications
- CAS
- 170851-70-4
- Formula
- C38H49N9O5
- Molecular weight
- 711.85 g/mol
- Sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Purity
- ≥99%
- Appearance
- White lyophilized powder
- Storage
- Store lyophilized at −20 °C, protected from light and moisture
Quality record
COA status
COA listedLot PTS-IPA-2607
Placeholder reference. Verify the active lot before ordering.
Research background
Ipamorelin is a pentapeptide ghrelin mimetic first characterized by Raun and colleagues at Novo Nordisk. Published research has described its action at the growth hormone secretagogue receptor (GHS-R1a) with notable selectivity for GH release over ACTH, cortisol, and prolactin in preclinical and early clinical studies.
In research contexts, Ipamorelin is frequently paired with a GHRH analog such as CJC-1295 to study the combined effect of two distinct pathways of pulsatile GH release.
The peptide is supplied exclusively as a laboratory reagent for investigation of GH axis physiology.
Mechanism: Literature describes Ipamorelin as a selective agonist at the ghrelin / growth hormone secretagogue receptor GHS-R1a, stimulating GH release from anterior pituitary somatotrophs.
Research use only
For research use only. Not for human or veterinary use.